We are building a vibrant, sustainable company with the goal of delivering transformational medicines.
Our therapeutically-focused pipeline is comprised of multiple development stage products, targeting a broad range of disease applications. Our aim is to efficiently advance each of our compounds to ensure that they may ultimately result in delivering benefits to patients.
We have established partnerships across a range of products, therapeutic areas and development stages. We will continue to support our existing collaborations and pursue future collaborations to accelerate specific programs.
We are committed to creating long-term value for our shareholders through careful management of resources against focused product development priorities.
View our latest press releases here